Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

516 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risankizumab Efficacy and Safety Based on Prior Inadequate Response or Intolerance to Advanced Therapy: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies.
Panaccione R, Louis E, Colombel JF, D'Haens G, Peyrin-Biroulet L, Dubinsky M, Takeuchi K, Rubin DT, Kalabic J, Chien KB, Chen S, Cheng L, Zhang Y, Duan WR, Vladea R, Hecht PM, Morisset P, Schreiber S, Ferrante M. Panaccione R, et al. Among authors: rubin dt. J Crohns Colitis. 2025 Jan 13:jjaf005. doi: 10.1093/ecco-jcc/jjaf005. Online ahead of print. J Crohns Colitis. 2025. PMID: 39804294
Point-of-care ultrasound in Gastroenterology and Hepatology.
Shankar N, Kuo L, Cleveland NK, Galen B, Samel NS, Perez-Sanchez A, Nathanson R, Coss E, Echavarria J, Rubin DT, Soni NJ. Shankar N, et al. Among authors: rubin dt. Clin Gastroenterol Hepatol. 2025 Jan 8:S1542-3565(25)00019-9. doi: 10.1016/j.cgh.2024.09.040. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 39793722 Free article. Review.
Tamuzimod in patients with moderately-to-severely active ulcerative colitis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 induction trial.
Sands BE, Panaccione R, D'Haens G, Schreiber S, Jairath V, DuVall A, Kierkus J, Walczak M, Naik S, Gilder K, Lindstrom B, Ogilvie K, Sandborn WJ, Vermeire S, Rubin DT, Peyrin-Biroulet L, Danese S. Sands BE, et al. Among authors: rubin dt. Lancet Gastroenterol Hepatol. 2025 Jan 7:S2468-1253(24)00386-8. doi: 10.1016/S2468-1253(24)00386-8. Online ahead of print. Lancet Gastroenterol Hepatol. 2025. PMID: 39793589
A Practical Guide to Diet and IBD.
Figueroa EJ, Venkat PG, Issokson K, Rubin DT, Lewis JD. Figueroa EJ, et al. Among authors: rubin dt. Am J Gastroenterol. 2024 Dec 31. doi: 10.14309/ajg.0000000000003266. Online ahead of print. Am J Gastroenterol. 2024. PMID: 39787366 No abstract available.
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis.
Vermeire S, Rubin DT, Peyrin-Biroulet L, Dubinsky MC, Regueiro M, Irving PM, Goetsch M, Lazin K, Gu G, Wu J, Modesto I, McDonnell A, Guo X, Green J, Dalam AB, Yarur AJ. Vermeire S, et al. Among authors: rubin dt. BMJ Open Gastroenterol. 2025 Jan 8;12(1):e001516. doi: 10.1136/bmjgast-2024-001516. BMJ Open Gastroenterol. 2025. PMID: 39778975 Free PMC article.
Prevalence and Risk Factors of Spondyloarthritis Symptoms in a US-Based Multicenter Cohort of Patients with Inflammatory Bowel Disease.
Hong SJ, Dalal RS, Kuhn KA, Stahly A, Scott F, Click B, Way A, Malik F, Davis JM 3rd, Shmais M, Raffals L, Silfen A, Rubin DT, Dharia I, Bhattacharya A, Moghaddam B, Mains T, Kurland J, Patel S, Weisman MH, Ermann J, Jan R. Hong SJ, et al. Among authors: rubin dt. Am J Gastroenterol. 2025 Jan 6. doi: 10.14309/ajg.0000000000003292. Online ahead of print. Am J Gastroenterol. 2025. PMID: 39760386
Frequency of Spondyloarthritis Symptoms Among U.S. Patients with Inflammatory Bowel Disease: A Cross-sectional Multi-Center Study.
Ermann J, Hong SJ, Stahly A, Dalal RS, Malik F, Scott FI, Click B, Way A, Davis JM 3rd, Shmais M, Raffals LE, Jan R, Silfen A, Rubin DT, Dharia I, Bhattacharya A, Moghaddam B, Mains T, Kurland JE, Patel S, Kuhn KA, Michael HW. Ermann J, et al. Among authors: rubin dt. Arthritis Care Res (Hoboken). 2025 Jan 2. doi: 10.1002/acr.25493. Online ahead of print. Arthritis Care Res (Hoboken). 2025. PMID: 39748206
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209 Clinical Trial.
516 results